» Articles » PMID: 27214510

Synthesis and Anticholinesterase Activity of Coumarin-3-carboxamides Bearing Tryptamine Moiety

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2016 May 24
PMID 27214510
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

A number of N-(2-(1H-indol-3-yl)ethyl)-2-oxo-2H-chromene-3-carboxamides were synthesized and tested against AChE and BuChE. The in vitro assessment of the synthesized compounds 4a-o revealed that most of them had significant activity toward AChE. The SAR study demonstrated that the introduction of benzyloxy moiety on the 7-position of coumarin scaffold can improve the anti-AChE activity. The best result was obtained with 7-(4-fluorobenzyl)oxy moiety in the case of compound 4o, displaying IC50 value of 0.16 μM. Based on the docking study of AChE, the prototype compound 4o was laid across the active site and occupied both peripheral anionic site (PAS) and catalytic anionic site (CAS).

Citing Articles

Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease.

Wu X, Ze X, Qin S, Zhang B, Li X, Gong Q Molecules. 2024; 29(8).

PMID: 38675602 PMC: 11051924. DOI: 10.3390/molecules29081782.


Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease.

Drakontaeidi A, Pontiki E Int J Mol Sci. 2024; 25(1).

PMID: 38203753 PMC: 10778916. DOI: 10.3390/ijms25010582.


Research status of indole-modified natural products.

Duan S, Song L, Guo H, Deng H, Huang X, Shen Q RSC Med Chem. 2023; 14(12):2535-2563.

PMID: 38107170 PMC: 10718587. DOI: 10.1039/d3md00560g.


Recent Development in the Search for Epidermal Growth Factor Receptor (EGFR) Inhibitors based on the Indole Pharmacophore.

Mishra S, Sahu A, Kaur A, Kaur M, Kumar J, Wal P Curr Top Med Chem. 2023; 24(7):581-613.

PMID: 37909440 DOI: 10.2174/0115680266264206231020111820.


Synthesis, Biological Evaluation, and Molecular Docking of Novel Azolylhydrazonothiazoles as Potential Anticancer Agents.

Al-Humaidi J, Gomha S, Riyadh S, Ibrahim M, Zaki M, Abolibda T ACS Omega. 2023; 8(37):34044-34058.

PMID: 37744790 PMC: 10515364. DOI: 10.1021/acsomega.3c05038.